Impact of 'LH activity' supplementation on serum progesterone levels during controlled ovarian stimulation: A systematic review

Human Reproduction

Volumn 27, Issue 1, 2012, Pages 232-243

  Hugues, J N ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

controlled ovarian stimulation; LH activity; progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GANIRELIX; GONADORELIN DERIVATIVE; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT LUTEINIZING HORMONE;

CONTROLLED OVARY STIMULATION; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HORMONE ACTION; HUMAN; INTRAUTERINE INSEMINATION; OBSTETRIC CARE; OOCYTE RETRIEVAL; OVARY FOLLICLE FLUID; PHYSIOLOGY; PROGESTERONE BLOOD LEVEL; REVIEW;

EID: 83755205804     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der380     Document Type: Review

References (64)

1. Adonakis G, Deshpande N, Yates R, Fleming R. Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle-stimulating hormone. Fertil Steril 1998;69:450-453.
2. Andersen AN, Devroey P, Arce JC. for the MERIT group. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod 2006;21:3217-3227. (Pubitemid 44811626)
3. Balasch J, Penarrubia J, Fabregues F, Vidal E, Casamitjana R, Manau D, Carmona F, Creus M, Vanrell JA. Ovarian responses to recombinant FSH or hMG in normogonadotropic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction. Reprod Biomed Online 2003;7:35-42. (Pubitemid 36874404)
4. Bentick B, Shaw RW, Iffland CA, Burford G, Bernard A. A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with buserelin for superovulation and in vitro fertilization. Fertil Steril 1988;50:79-84.
5. Blockeel C, De Vos M, Verpoest W, Stoop D, Haentjens P, Devroey P. Can 200 UI of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study. Hum Reprod 2009; 24:2910-2916.
6. Bosch E, Valencia I, Escudero E, Crespo J, Simon C, Remohi J, Pellicer A. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 2003;80:1444-1449. (Pubitemid 37532460)
7. Bosch E, Escudero E, Crespo J, Simon C, Remohi J, Pellicer A. Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome. Fertil Steril 2005;84:1529-1532. (Pubitemid 41571915)
8. Bosch E, Vidal C, Labarta E, Simon C, Remohi J, Pellicer A. Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists-a randomized study. Hum Reprod 2008;23:2346-2351.
9. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Jenkins J, Pellicer A. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod 2010;25:2092-2100.
10. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Pellicer A. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril 2011; 95:1031-1036.
11. Cédrin-Durnerin I, Grange-Dujardin D, Laffy A, Parneix I, Massin N, Galey J, Theron L, Wolff P, Conord C, Clement P et al. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2004; 19:1979-1984. (Pubitemid 39242642)
12. Check JH, O'Shaughnessy A, Nazari A, Hoover L. Comparison of efficacy of high dose pure follicle stimulating hormone versus human menopausal gonadotropins for in vitro fertilization. Gynecol Obstet Invest 1995;40:117-119.
13. Coucke M, Devleeschouwer N, Libeer JC, Schiettecatte J, Martin M, Smitz J. Accuracy and reproducibility of automated estradiol-17b and progesterone assys using native serum samples: results obtained in the Belgian external assessment scheme. Hum Reprod 2007; 22:3204-3209. (Pubitemid 351696783)
14. De Ziegler D, Bijaoui G, Chaperon C. Pre-hCG elevation of plasma progesterone: good, bad or otherwise. Hum Reprod Update 2008;14:393. (Pubitemid 351858979)
15. Djuijkers IJM, Vemer HM, Hollanders JMG, Willemsen WNP, Bastiaans LA, Hamilton CJCM, Thomas CMG, Born GF. Different follicle stimulating hormone/luteinizing hormone ratios for ovarian stimulation. Hum Reprod 1993;8:1387-1391. (Pubitemid 23265967)
16. Djuijkers IJM, Willemsen WNP, Hollanders HMG, Hamilton CJCM, Thomas CMG, Vemer HM. Follicular fluid hormone concentration using gonadotropin preparations with different FSH/LH ratio. II. Comparison of hMG and recombinant FSH. Int J Fertil 1997;42:431-43.
17. Elgindy EA. Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy. Fertil Steril 2011;95:1639-1644.
18. Fanchin R, Righini C, Olivennes F, Ferreira AL, de Ziegler D, Frydman R. Consequences of premature progesterone elevation on the outcome of in vitro fertilization : insignts into a controversy. Fertil Steril 1997; 68:799-805. (Pubitemid 27506090)
19. Ferraretti AP, Gianaroli L, Magli MC, D'Angelo A, Farfalli V, Montanaro N. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction technics. Fertil Steril 2004;82:1521-1526. (Pubitemid 39611376)
20. Filicori M, Flamigni C, Cognigni GE, Falbo A, Arnone R, Capelli M, Pavani A, Mandini M, Calderoni P, Brondelli L. Different gonadotropin and leuprolide ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis. Fertil Steril 1996;65:387-393. (Pubitemid 26043839)
21. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, Tabarelli de Fatis C, Pocognoli P. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab 1999;84:2659-2663. (Pubitemid 30641989)
22. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, Tabarelli de Fatis C, Pocognoli P, Cantelli B, Boschi S. Luteinzing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. J Clin Endocrinol Metab 2001;86:337-343. (Pubitemid 32109815)
23. Filicori M, Cognigni GE, Tabarelli C, Pocognoli P, Taraborrelli S, Spettoli D, Ciampaglia W. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab 2002a;87:1156-1161. (Pubitemid 36121081)
24. Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Spettoli D, Taraborrelli S, Ciampaglia W. Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration. Hum Reprod 2002b; 17:2009-2015.
25. Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Ferlini F, Perri T, Parmegiani L. Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone. Fertil Steril 2003;80:390-397. (Pubitemid 36959799)
26. Filicori M, Cognigni FE, Gamberini E, Parmegiani L, Troilo E, Roset B. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril 2005;84:394-401. (Pubitemid 41125260)
27. Fleming R. Progesterone elevation on the day of hCG: methodological issues. Hum Reprod Update 2008;14:391-392. (Pubitemid 351858978)
28. Fleming R, Chung CC, Yates RWS, Coutts JRT. Purified urinary follicle stimulating hormonee induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity. Hum Reprod 1996; 11:1854-1858. (Pubitemid 26381426)
29. Gomes MKO, Vieira CS, Moura D, Luiz A, Manatta A, Leite SP, Reis RM, Ferriani RA. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG. Eur J Obstet Gynaecol Reprod Biol 2007;130:90-106.
30. Gordon UD, Harrisson RF, Fawzy M, Hennelly B, Gordon AC. A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil Steril 2001; 75:324-331. (Pubitemid 32112109)
31. Griesinger G, Schultze-Mosgan A, Dafopoulos K, Schroeder A, Schroer A, von Otte S, Hornung D, Diedrich K, Felberbaum R. Recombinant luteinizing hormone supplementation to recombinant follicule-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Hum Reprod 2005; 20:1200-1206. (Pubitemid 40790242)
32. Harada T, Katagiri C, Takao N, Toda T, Moi Y, Terakawa N. Altering the timing of human chorionic gonadotropin injection according to serum progesterone (P) concentrations improves embryo quality in cycles with subtle P rise. Fertil Steril 1996;65:594-597. (Pubitemid 26074105)
33. Hugues JN, Massé-Laroche E, Reboul-Marty J, Boiko O, Meynant C, Cédrin-Durnerin I. Impact of endogenous LH serum levels on progesterone elevation on the day of hCG. Fertil Steril 2011;96:600-604.
34. Imthurn B, Macas E, Rosselli M, Keller PJ. Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin. Hum Reprod 1996;11:2387-2391. (Pubitemid 127540244)
35. Kilani Z, Dakkak A, Ghunaim S, Cognigni GE, Tabarelli C, Parmegiani L, Filicori M. A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes. Hum Reprod 2003; 18:1194-1199. (Pubitemid 36740563)
36. Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, Devroey P. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril. 2002; 78:1025-1029. (Pubitemid 35292504)
37. Kolibianakis EM, Venetis CA, Bontis J, Tarlatzis BC. Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis. Curr Pharm Biotechnol 2011; June 9 (Epub ahead of print).
38. Kovacs P, Kovats T, Kaali S. Results with early follicular recombinant luteinizing hormone supplementation during stimulation for in vitro fertilization. Fertil Steril 2010;93:475-479.
39. Kyrou D, Popovic-Todorovic B, Fatemi HM, Bourgain C, Haentjens P, Van Landuyt L, Devroey P. Does the estradiol level on the day of human Chorionic Gonadotrophin administration have an impact on pregnancy rate in patients treated with rec-FSH/GnRH antagonist? Hum Reprod 2009a;24:2902-2909.
40. Kyrou D, Kolibianakis EM, Venetis CA, Miliaras D, Theodoridis T, Tzevelekis F, Bontis J, Tarlatzis BC. Steroid receptor expression in human endometrium during the follicular phase of stimulated cycles. Hum Reprod 2009b;24:2931-2935.
41. Kyrou D, Kolibianakis EM, Fatemi HM, Camus M, Tournaye H, Tarlatzis BC, Devroey P. High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril 2011;96:884-888.
42. Labarta E, Martinez-Conejero JA, Alama P, Horcajadas JA, Pellicer A, Simon C, Bosch E. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod 2011;26:1813-1825.
43. Lindeberg M, Carlstrom K, Ritvos O, Hovatta O. Gonadotrophin stimulation of non luteinized granulosa cells increases steroid production and the expression of enzymes involved in estrogen and progesterone synthesis. Hum Reprod 2007;22:401-406. (Pubitemid 46152559)
44. Lossl K, Yding Andersen C, Loft A, Freiesleben NLC, Bangsboll S, Andersen AN. Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial. Hum Reprod 2008;23:1820-1829. (Pubitemid 352020003)
45. Melo MAB, Meseguer M, Garrido N, Bosch E, Pellicer A, Remohi J. The significance of premature luteinisation in an oocyte-donation programme. Hum Reprod 2006;21:1503-1507. (Pubitemid 44445028)
46. Melo M, Bellver J, Garrido N, Meseguer M, Pellicer A, Remohi J. A prospective, randomized; controlled trial comparing three different gonadotroin regimens in oocyte donors: ovarian response, in vitro fertilization outcome and analysis of cost minimization. Fertil Steril 2010;94:958-964.
47. Murphy BD. Models of luteinisation. Biol Reprod 2000;63:2-11.
48. Orvieto R, Homburg R, Meltcer S, Rabinson J, Arteby E, Nahum R. HMG improves IVF outcome in patients with high basal FSH/LH ration: a preliminary study. Reprod Biomed Online 2009;18:205-208.
49. Papanikolaou E, Kolibianakis EM, Pozzobon C, Tank P, Tournaye H, Bourgain C, Van Steirteghem A, Devroey P. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer while has no effect on day 5 single blastocyst transfer. Fertil Steril 2009;91:949-952.
50. Payne AH, Hales D. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 2004; 25:947-970. (Pubitemid 39657774)
51. Requena A, Landeras J, Martinez-Navarro L, Calatayud C, Sanchez F, Maldonado V, Munoz M, Fernandez M, Gonzalez A, Lopez S et al. Could the addition of hp-hMG and GnRH antagonists modulate the response in IVF-ICSI cycles? Hum Fertil (Camb) 2010;13:41-51.
52. Sauer MV, Thornton MH II, Schoolcraft W, Frishman GN. Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction. Reprod Biomed Online 2004; 9:487-493. (Pubitemid 39517491)
53. Schoolcraft W, Sinton E, Schlenker T, Huynh D, Hamilton F, Meldrum DR. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991; 56:563-566.
54. Serafini P, Yadid I, Motta EL, Alegretti JR, Fioravanti J, Coslovsky M. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial. Fertil Steril 2006;86:830-838. (Pubitemid 44485029)
55. Smitz J, Andersen AN, Devroey P, Arce JC. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with hp-hMG or recombinant FSH in IVF patients. Hum Reprod 2007;22:676-687.
56. Teissier MP, Chable H, Paulhac S, Aubard Y. Recombinant human follicle stimulating hormone versus human menoapusal gonadotrohin induction: effects in mature follicle endocrinology. Hum Reprod 1999; 14:2236-2241. (Pubitemid 29425405)
57. The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH - and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 1998;83:1507-1513.
58. Ubaldi F, Camus M, Smitz J, Coelingh Benninck H, Van Sterteghem A, Devroey P. Premature luteinisation in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril 1996;66:275-280. (Pubitemid 26244463)
59. Van Vaerenberg M, Blockeel C, Van Lommel L, In't Veld P, Schuit F, Kolibianakis EM, Devroey P, Bourgain C. Progesterone rise on hCG day in GnRH antagonist/FSH stimulated cycles affects endometrial gene expression. Reprod Biomed Online 2011;22:263-271.
60. Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update 2007;13:343-355. (Pubitemid 47062828)
61. Yding Andersen C, Bungun L, Nyboe Andersen A, Humaidan P. Preovulatory progesterone concentrations associated significantly to follicle number and LH concentrations but not to pregnancy rate. Reprod Biomed Online 2011;23:187-195.
62. Young EL, Baird DT, Reichert LE, Hillier SG. Hormonal regulation of the growth and steroidogenic function of human granulose cells. Hum Reprod 1992;74:842-849.
63. Young EL, Hillier SG, Turner M, Baird DT, Ng SC, Bongso A, Ratnam SS. Differential regulation of cholesterol side-chain cleavage (P450scc) and aromatase (P450arom) enzyme mRNA expression by gonadotrophins and cyclic AMP in human granulose cells. J Mol Endocrinol 1994; 12:239-249. (Pubitemid 24153645)
64. Younis JS. Elevated P level on the day of hCG administration is related to FSH dose: is it whole truth? Hum Reprod 2011;26:498-499.